Suppr超能文献

医疗保险受益人群中新阿片类药物使用的特征:识别高风险模式。

Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.

机构信息

Department of Population Health Sciences, Duke University School of Medicine, and Duke Clinical Research Institute, Duke University, Durham, North Carolina.

Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.

出版信息

J Manag Care Spec Pharm. 2019 Sep;25(9):966-972. doi: 10.18553/jmcp.2019.25.9.966.

Abstract

BACKGROUND

Opioid prescription patterns, including long-term use, multiple prescribers, and high opioid doses, increase the risk for adverse outcomes; however, previous research in older adult populations has primarily described opioid dose patterns using average daily dose measures or using very high thresholds (i.e., > 100 morphine milligram equivalents [MME] per day).

OBJECTIVE

To describe prescription patterns by peak dose among older adults who have newly initiated opioid use in 2014 and describe long-term opioid use and the use of multiple pharmacies and prescribers among those with peak opioid doses over 50 and over 90 MME per day.

METHODS

This was a retrospective cohort study of Medicare Part D prescription claims data (5% sample) for beneficiaries aged 65 years and older who were prescribed ≥ 1 opioid prescription in 2014 and did not have an opioid prescription in the preceding 180 days. Within a 1-year period of follow-up, we used prescription claims to characterize individuals' opioid exposure, measuring long-term opioid use (≥ 90 days of continuous opioid supply), unique opioid prescribers, and unique opioid-dispensing pharmacies. Peak MME was defined as the maximum daily MME received across all overlapping opioid prescriptions in the observation period.

RESULTS

144,127 beneficiaries without an opioid prescription in the previous 6 months filled ≥ 1 opioid prescription in 2014. During the 1-year follow-up period, 6.5% of beneficiaries transitioned to long-term opioid use; 39.5% received opioid prescriptions from > 1 prescriber; 18.1% filled opioid prescriptions from > 1 pharmacy; and 21.8% had a peak MME of 50-89. Among the 28.1% of beneficiaries exposed to a peak MME > 50, 8.6% developed long-term opioid use; 7.0% had 3 or more opioid dispensing pharmacies; and 28.0% had 3 or more opioid prescribers. Among the 6.2% of beneficiaries exposed to a peak MME ≥ 90, 18.5% developed long-term opioid use; 13.0% had 3 or more opioid dispensing pharmacies; and 39.6% had 3 or more opioid prescribers.

CONCLUSIONS

High doses of opioids were prescribed for about one quarter (28%) of Medicare beneficiaries with new opioid use in 2014. Having multiple opioid prescribers or multiple opioid dispensing pharmacies was common, especially among those prescribed higher doses. These prescription patterns can be particularly helpful to identify older adults with increased opioid-related risk.

DISCLOSURES

No funding supported this study. Raman reports research grants from GlaxoSmithKline not related to this study. Roberts was supported by a CTSA grant from NCATS awarded to the University of Kansas Medical Center for Frontiers: The Heartland Institute for Clinical and Translational Research (#KL2TR000119). The other authors have no potential conflicts to report.

摘要

背景

阿片类药物处方模式,包括长期使用、多个处方医生和高阿片类药物剂量,会增加不良后果的风险;然而,先前在老年人群体中的研究主要使用平均日剂量或非常高的阈值(即> 100 吗啡毫克当量 [MME] /天)来描述阿片类药物剂量模式。

目的

描述 2014 年新开始使用阿片类药物的老年人中峰值剂量的处方模式,并描述长期使用阿片类药物以及那些峰值阿片类药物剂量超过 50 和超过 90 MME /天的患者使用多个药房和处方医生的情况。

方法

这是一项针对 Medicare Part D 处方索赔数据(5%的样本)的回顾性队列研究,纳入 2014 年至少开了 1 次阿片类药物处方且在之前 180 天内没有阿片类药物处方的年龄在 65 岁及以上的受益人群。在为期 1 年的随访期间,我们使用处方索赔来描述个体的阿片类药物暴露情况,衡量长期使用阿片类药物(连续接受阿片类药物治疗≥ 90 天)、独特的阿片类药物处方医生和独特的阿片类药物配药药房。峰值 MME 定义为观察期内所有重叠阿片类药物处方中最大每日 MME。

结果

在过去 6 个月内没有阿片类药物处方的 144127 名受益人群在 2014 年开了至少 1 次阿片类药物处方。在 1 年的随访期间,6.5%的受益人群转为长期使用阿片类药物;39.5%的受益人群接受了来自> 1 名处方医生的阿片类药物处方;18.1%的受益人群从> 1 家药房领取阿片类药物处方;21.8%的受益人群峰值 MME 为 50-89。在 28.1%的暴露于峰值 MME> 50 的受益人群中,8.6%的人发展为长期使用阿片类药物;7.0%的人有 3 家或更多的阿片类药物配药药房;28.0%的人有 3 名或更多的阿片类药物处方医生。在 6.2%的暴露于峰值 MME≥ 90 的受益人群中,18.5%的人发展为长期使用阿片类药物;13.0%的人有 3 家或更多的阿片类药物配药药房;39.6%的人有 3 名或更多的阿片类药物处方医生。

结论

大约四分之一(28%)的 2014 年新开始使用阿片类药物的 Medicare 受益人群接受了高剂量的阿片类药物。有多个阿片类药物处方医生或多个阿片类药物配药药房的情况很常见,尤其是在那些接受更高剂量处方的人群中。这些处方模式特别有助于识别有增加阿片类药物相关风险的老年人群。

披露

本研究没有资金支持。Raman 报告了与本研究无关的葛兰素史克公司的研究资助。Roberts 得到了美国国家卫生研究院临床与转化科学奖(NCATS)授予堪萨斯大学医学中心的前沿奖:心脏地带临床和转化科学研究所 (#KL2TR000119) 的资助。其他作者没有潜在的利益冲突需要报告。

相似文献

引用本文的文献

本文引用的文献

7
Trends in Opioid Use and Prescribing in Medicare, 2006-2012.2006-2012 年 Medicare 中阿片类药物使用和处方的趋势。
Health Serv Res. 2018 Oct;53(5):3309-3328. doi: 10.1111/1475-6773.12846. Epub 2018 Mar 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验